Evidence map›Paper›PMID 27797808›Full record

ArticleBrain : a journal of neurology2016

Clinicopathological features of adult-onset neuronal intranuclear inclusion disease.

Jun Sone, Keiko Mori, Tomonori Inagaki, Ryu Katsumata, Shinnosuke Takagi, Satoshi Yokoi, Kunihiko Araki, Toshiyasu Kato, Tomohiko Nakamura, Haruki Koike and 22 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 227 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
227citing papers in PubMed, 3 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

227 citing papers in PubMed, 3 syntheses or guidelines pooled it, 397 citations in OpenAlex.

  1. Neuronal intranuclear inclusion disease with stroke-mimicking onset: a case report and systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Structural Polymorphism of polyG Inclusions Revealed by In Situ Cryo-Electron Tomography.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

167 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 15 institutions in 1 country.

Jun Sone1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Keiko Mori1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Tomonori Inagaki1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Ryu Katsumata1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Shinnosuke Takagi1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Satoshi Yokoi1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Kunihiko Araki1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Toshiyasu Kato1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Tomohiko Nakamura1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Haruki Koike1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Hiroshi Takashima4 Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Akihiro Hashiguchi4 Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Yutaka Kohno5 Department of Neurology, Ibaraki Prefectural University of Health Sciences, Ami, Ibaraki, Japan.
Takashi Kurashige6 Department of Neurology, National Hospital Organization Kure Medical Centre, Kure, Hiroshima, Japan.
Masaru Kuriyama7 Department of Neurology, Ota Memorial Hospital, Fukuyama, Hiroshima, Japan.
Yoshihisa Takiyama8 Department of Neurology, University of Yamanashi, Kofu, Yamanashi, Japan.
Mai Tsuchiya8 Department of Neurology, University of Yamanashi, Kofu, Yamanashi, Japan.
Naoyuki Kitagawa9 Department of Neurology, Kosei Chuo General Hospital, Tokyo, Japan.
Michi Kawamoto10 Department of Neurology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Hajime Yoshimura10 Department of Neurology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Yutaka Suto11 Department of Neurology, Tottori Prefectural Central Hospital, Tottori, Japan.
Hiroyuki Nakayasu11 Department of Neurology, Tottori Prefectural Central Hospital, Tottori, Japan.
Naoko Uehara12 Department of Neurology, National Hospital Organization Utano Hospital, Kyoto, Japan.
Hiroshi Sugiyama12 Department of Neurology, National Hospital Organization Utano Hospital, Kyoto, Japan.
Makoto Takahashi13 Department of Neurology, Kanto Central Hospital, Tokyo, Japan.
Norito Kokubun14 Department of Neurology, Dokkyo Medical University, Tochigi, Japan.
Takuya Konno15 Department of Neurology, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan.
Masahisa Katsuno1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Fumiaki Tanaka16 Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Yasushi Iwasaki17 Department of Neuropathology, Institute for Medical Sciences of Aging, Aichi Medical University, Nagakute, Aichi, Japan.
Mari Yoshida17 Department of Neuropathology, Institute for Medical Sciences of Aging, Aichi Medical University, Nagakute, Aichi, Japan.
Gen Sobue1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan sobueg@med.nagoya-u.ac.jp.
Nagoya University · JPAichi Medical University · JPKagoshima University · JPKobe City Medical Center General Hospital · JPNational Hospital Organization · JPTottori Prefectural Central Hospital · JPUniversity of Yamanashi · JPDokkyo Medical University · JPFuji Heavy Industries Health Insurance Society Ota Memorial Hospital · JPIbaraki Prefectural University of Health Sciences · JPKanto Central Hospital · JPNagaoka Red Cross Hospital · JPSapporo Kosei General Hospital · JPUtano Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal intranuclear inclusion disease (NIID) is a slowly progressive neurodegenerative disease characterized by eosinophilic hyaline intranuclear inclusions in the central and peripheral nervous system, and also in the visceral organs. NIID has been considered to be a heterogeneous disease because of the highly variable clinical manifestations, and ante-mortem diagnosis has been difficult. However, since we reported the usefulness of skin biopsy for the diagnosis of NIID, the number of NIID diagnoses has increased, in particular adult-onset NIID. In this study, we studied 57 cases of adult-onset NIID and described their clinical and pathological features. We analysed both NIID cases diagnosed by post-mortem dissection and by ante-mortem skin biopsy based on the presence of characteristic eosinophilic, hyaline and ubiquitin-positive intanuclear inclusion: 38 sporadic cases and 19 familial cases, from six families. In the sporadic NIID cases with onset age from 51 to 76, dementia was the most prominent initial symptom (94.7%) as designated 'dementia dominant group', followed by miosis, ataxia and unconsciousness. Muscle weakness and sensory disturbance were also observed. It was observed that, in familial NIID cases with onset age less than 40 years, muscle weakness was seen most frequently (100%), as designated 'limb weakness group', followed by sensory disturbance, miosis, bladder dysfunction, and dementia. In familial cases with more than 40 years of onset age, dementia was most prominent (100%). Elevated cerebrospinal fluid protein and abnormal nerve conduction were frequently observed in both sporadic and familial NIID cases. Head magnetic resonance imaging showed high intensity signal in corticomedullary junction in diffusion-weighted image in both sporadic and familial NIID cases, a strong clue to the diagnosis. All of the dementia dominant cases presented with this type of leukoencephalopathy on head magnetic resonance imaging. Both sporadic and familial NIID cases presented with a decline in Mini-Mental State Examination and Frontal Assessment Battery scores. Based on these clinicopathological features, we proposed a diagnosis flow chart of adult-onset NIID. Our study suggested that the prevalence rate of adult-onset NIID may be higher than previously thought, and that NIID may be underdiagnosed. We should take NIID into account for differential diagnosis of leukoencephalopathy and neuropathy.

Indexed as

AdolescentAdultAgedAge of OnsetDementiaFemaleHumansIntranuclear Inclusion BodiesMagnetic Resonance ImagingMaleMiddle AgedMuscle WeaknessNeurodegenerative DiseasesPedigreeYoung Adultdementiadiffusion-weighted imageintranuclear inclusionleukoencephalopathyskin biopsy

Identifiers

PMID27797808
PMCPMC5382941
OpenAlexW2537451930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.